Anti-CD44 (FITC), clone OX-50

Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
ARG23080.50 50 µg - -

6 - 14 Werktage*

560,00 €
 
Protein function: Receptor for hyaluronic acid (HA). Mediates cell-cell and cell-matrix... mehr
Produktinformationen "Anti-CD44 (FITC), clone OX-50"
Protein function: Receptor for hyaluronic acid (HA). Mediates cell-cell and cell-matrix interactions through its affinity for HA, and possibly also through its affinity for other ligands such as osteopontin, collagens, and matrix metalloproteinases (MMPs). Adhesion with HA plays an important role in cell migration, tumor growth and progression. In cancer cells, may play an important role in invadopodia formation. Also involved in lymphocyte activation, recirculation and homing, and in hematopoiesis. Receptor for LGALS9, the interaction enhances binding of SMAD3 to the FOXP3 promoter, leading to up-regulation of FOXP3 expression and increased induced regulatory T (iTreg) cell stability and suppressive function. [The UniProt Consortium]
Schlagworte: Anti-Cd44, Anti-CD44, Anti-PGP-1, Anti-PGP-I, Anti-HUTCH-I, Anti-ECMR-III, Anti-CD44 antigen, Anti-Hermes antigen, Anti-Hyaluronate receptor, Anti-Phagocytic glycoprotein 1, Anti-Phagocytic glycoprotein I, Anti-Extracellular matrix receptor III
Hersteller: Arigo Biolaboratories
Hersteller-Nr: ARG23080

Eigenschaften

Anwendung: FC
Antikörper-Typ: Monoclonal
Klon: OX-50
Konjugat: FITC
Wirt: Mouse
Spezies-Reaktivität: rat
Immunogen: Rat T cell blasts
Format: Purified

Datenbank Information

UniProt ID : P26051 | Passende Produkte
Gene ID GeneID 25406 | Passende Produkte

Handhabung & Sicherheit

Lagerung: +4°C
Versand: +4°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-CD44 (FITC), clone OX-50"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen